We are excited to welcome Dr. Pamela Klein to our board of directors. Dr. Klein is a medical oncologist and senior biotechnology executive with over 20 years of experience who has advanced important cancer therapies to patients. #boardofdirectors

We’re excited to finally reconvene in person for this week’s 41st Annual J.P. Morgan Health Care Conference. If you are here, please join our CEO, Chris Varma, for his presentation. January 11, 2023, 10:00 a.m. PST #JPM23 #Biotech

Thanks Luke Timmerman for braving the floods and the hail to speak with our CEO, Chris Varma. The things we do for science! #JPM23

Our executive team is hosting meetings at the SVB Global Biopharma Conference. We hope to (virtually) see you there!

Kainat vividly recalls being the only girl at 4th grade math camp and advanced computing classes. Luckily for our Frontier™ Platform team, that only fueled her passion for STEM. This #February11, we applaud Kainat and all the #WomeninScience at Frontier and everywhere. #Biotech

At 12, Kyle knew she wanted to be a scientist. Now, she is helping to discover new breakthroughs for patients. We are proud to support scientists, especially the #WomeninScience here at Frontier. Tomorrow is International Day of Women & Girls in Science! #February11 #Biotech

Please join us in welcoming Christo as Frontier’s SVP and Head of Business Development! His global pharma background coupled with his leadership experience in growing biotechs will be invaluable as we continue on our rapid trajectory. bit.ly/welcomechristo #biotech

We are excited to join our colleagues in #biotech at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #oncology #chemoproteomics #undruggable rb.gy/hnkzbn

We are excited to join the oncology community this week at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #cancer

We’re excited to unveil new preclinical data on our lead candidate, FMC-376, at #AACR23 More here: bit.ly/3mAEJRX

Thanks Sally Church, we’re feeling the AACR sunshine here at Frontier.

Today at #AACR23, we’re talking about the Frontier™ platform, which gives us the tools to open new frontiers in drugging the undruggable. Visit poster 5333 (Section 30, Board 15). Learn more here: frontiermeds.com/science-platfo…

Decades after the human genome project, only 15% of the human proteome has approved treatments. We’re opening up new Frontiers in what is possible. Learn more here: frontiermeds.com/science-platfo… #DNADay #DNADay23 #biotech #chemoproteomics

This month, and every month, we honor and celebrate the LGBTQIA+ community. #PrideMonth #Pride2023

Are you at #BIO2023? Will the IPO market return? Join our CEO, Chris Varma, and leading experts in the field, as they discuss the current biotech financial climate. This afternoon at 2:15 p.m. ET Room 210A #standupforscience

Our science never stops, but today our offices are closed, as we recognize the importance of #Juneteenth. #listeningandlearning

The Frontier Medicines team wishes everyone in the U.S. a happy and healthy #July4th!

A couple of important gems from the (over-crowded) poster halls really stood out for me this year at #AACR24. Will have some important clinical implications should the concept hold up in patients: bit.ly/49AXKGn